A Short Approach to N-Aryl-1,2,3,4-tetrahydroisoquinolines from N-(2-Bromobenzyl)anilines via a Reductive Amination/Palladium-Catalyzed Ethoxyvinylation/Reductive N-Alkylation Sequence

Abstract

N-Aryl-1,2,3,4-tetrahydroisoquinolines are obtained via a convenient and short protocol with a broad range of substituents on both aromatic rings and high functional group tolerance. Starting from readily available ortho-brominated aromatic aldehydes and primary aromatic amines, condensation of these building blocks under reductive conditions gives N-aryl 2-bromobenzylamines. The C-3/C-4-unit of the tetrahydroisoquinoline is introduced using commercially available 2-ethoxyvinyl pinacolboronate under Suzuki conditions. Finally, the obtained crude ortho-ethoxyvinyl benzylamines are cyclized via an intramolecular reductive amination using the combination of triethylsilane/TFA to give the desired N-aryl-1,2,3,4-tetrahydroisoquinolines.

Key words

N-aryl-1,2,3,4-tetrahydroisoquinolines - reductive cyclization - Pd-catalyzed ethoxyvinylation - reductive N-alkylation - cross-coupling

Publikationsverlauf

Eingereicht: 20. Oktober 2020

Angenommen nach Revision: 30. November 2020

Artikel online veröffentlicht:
07. Januar 2021

• References

• 1a The Chemistry and Biology of Isoquinoline Alkaloids . Phillipson JD, Roberts MF, Zenk MH. Springer-Verlag; Berlin: 1985
• 1b Qing Z.-X, Huang J.-L, Yang X.-Y, Liu J.-H, Cao H.-L, Xiang F, Cheng P, Zeng J.-G. Curr. Med. Chem. 2018; 25: 5088
• 2a Lubisch W, Moeller A, Treiber H.-J, Knopp M. US6482832B1, 2002
• 2b Burke PJ, Wong LC, Jenkins TC, Knox RJ, Stanforth SP. Bioorg. Med. Chem. Lett. 2011; 21: 7447
• 2c Kalgutkar AS, Frederick KS, Chupka J, Feng B, Kempshall S, Mireles RJ, Fenner KS, Troutman MD. J. Pharm. Sci. 2009; 98: 4914
• 2d Vernier J.-M, De La Rosa MA, Chen H, Wu JZ, Larson GL, Cheney IW.
• 2e Buchanan JL, Bregman H, Chakka N, Dimauro EF, Du B, Nguyen HN, Zheng XM. WO2010022055A2, 2010
• 3a Barlaam B, Dantzman C. WO200246164A1, 2002
• 3b Adams GL, Cox JM, Debenham JS, Edmondson S, Gilbert E, Guo Y, Jiang Y, Josien H, Kim HM, Lan P, Miao S, Plummer CW, Rajagopalan M, Shah U, Sun Z, Suzuki T, Truong QT, Ujjainwalla F, Velazquez F, Venkatraman S, Wang N. WO2017201683A1, 2017
• 3c Funke U, Fischer S, Hiller A, Scheunemann M, Deuther-Conrad W, Brust P, Steinbach J. Bioorg. Med. Chem. Lett. 2008; 18: 4727
• 4a Álvarez M, Joule JA. Product Class 5: Isoquinolines. In Section 15.5, Science of Synthesis: Category 2, Hetarenes and Related Ring Systems, Vol. 15. Black DStC. Georg Thieme Verlag; Stuttgart: 2005: 661
• 4b Chrzanowska M, Grajewska A, Rozwadowska MD. Chem. Rev. 2016; 116: 12369
• 5 Reimann E, Höglmüller A. Arch. Pharm. 1985; 318: 559
• 6a Buckley BR, Christie SD. R, Elsegood MR. J, Gillings CM, Page PC. B, Pardoe WJ. M. Synlett 2010; 939
• 6b Forni JA, Brzozowski M, Tsanaktsidis J, Savage GP, Polyzos A. Aust. J. Chem. 2015; 68: 1890
• 6c Li Z, Li C.-J. J. Am. Chem. Soc. 2005; 127: 6968
• 6d Quach TD, Batey RA. Org. Lett. 2003; 5: 4397
• 6e Ueda H, Yoshida K, Tokuyama H. Org. Lett. 2014; 16: 4194
• 7a Hodson HF, Batchelor JF, Selway JW. T, Vinter JG, Iyer R. US4801593, 1989
• 7b Almena J, Foubelo F, Yus M. Tetrahedron 1996; 52: 8545
• 7c Ma Y.-N, Yang X.-J, Pan L, Hou Z, Geng H.-L, Song X.-P, Zhou L, Miao F. Chem. Pharm. Bull. 2013; 61: 204
• 8 Mottinelli M, Leese MP, Potter BV. L. Beilstein J. Org. Chem. 2017; 13: 1871
• 9a Schütz R, Meixner M, Antes I, Bracher F. Org. Biomol. Chem. 2020; 18: 3047
• 9b Schütz R, Schmidt S, Bracher F. Tetrahedron 2020; 76: 131150
• 9c Schütz R, Müller M, Gerndt S, Bartel K, Bracher F. Arch. Pharm. 2020; 353: e2000106
• 9d Schütz R, Müller M, Geisslinger F, Vollmar A, Bartel K, Bracher F. Eur. J. Med. Chem. 2020; 207: 112810
• 9e Melzer BC, Bracher F. Beilstein J. Org. Chem. 2017; 13: 1564
• 9f Melzer BC, Felber JG, Bracher F. Beilstein J. Org. Chem. 2018; 14: 130
• 9g Melzer B, Bracher F. Org. Biomol. Chem. 2015; 13: 7664
• 10 Glas C, Dietschreit JC. B, Wössner N, Urban L, Ghazy E, Sippl W, Jung M, Ochsenfeld C, Bracher F. Eur. J. Med. Chem. 2020; 206: 112676
• 11 Kamlah A, Bracher F. Lett. Org. Chem. 2019; 16: 931
• 12a Vögerl K, Ong DN, Bracher F. Synthesis 2018; 50: 1323
• 12b Bracher F. SynOpen 2018; 2: 96
• 12c Vögerl K, Ong N, Senger J, Herp D, Schmidtkunz K, Marek M, Müller M, Bartel K, Shaik TB, Porter NJ, Robaa D, Christianson DW, Romier C, Sippl W, Jung M, Bracher F. J. Med. Chem. 2019; 62: 1138
• 13 Popp TA, Uhl E, Ong DN, Dittrich S, Bracher F. Tetrahedron 2016; 72: 1668
• 14a Zhang X.-L, Yu P, Wu Y.-W, Wu Q.-P, Zhang Q.-S. J. Chem. Res. 2014; 38: 261
• 14b Chen B.-C, Sundeen JE, Guo P, Bednarz MS, Zhao R. Tetrahedron Lett. 2001; 42: 1245
• 15 Barder TE, Walker SD, Martinelli JR, Buchwald SL. J. Am. Chem. Soc. 2005; 127: 4685
• 16 Sakamoto T, Kondo Y, Yasuhara A, Yamanaka H. Tetrahedron 1991; 47: 1877
• 17 For related observations on N-methylations using 1,3,5-trioxane and triethylsilane/TFA, see: Popp TA, Bracher F. Synthesis 2015; 47: 3333
• 18 Swinnen D, Gerber P, Gonzalez J, Bombrun A, Jorand-Lebrun C. WO2005012280A1, 2005
• 19a Earley RA, Gallagher MJ. J. Organomet. Chem. 1969; 20: 117
• 19b Jiang M, Li J, Wang F, Zhao Y, Zhao F, Dong X, Zhao W. Org. Lett. 2012; 14: 1420
• 20 Xu Y, Xu Z.-J, Liu Z.-P, Lou H. Org. Chem. Front. 2019; 6: 3902
• 21 Gaertzen O, Buchwald SL. J. Org. Chem. 2002; 67: 465
• 22 Sud A, Sureshkumar D, Klussmann M. Chem. Commun. 2009; 3169
• 23 Wang J, Sun Y, Wang G, Zhen L. Eur. J. Org. Chem. 2017; 6338
• 24 Chen K, Pullarkat SA. Org. Biomol. Chem. 2012; 10: 6600
• 25 Baechler SA, Fehr M, Habermeyer M, Hofmann A, Merz K.-H, Fiebig H.-H, Marko D, Eisenbrand G. Bioorg. Med. Chem. 2013; 21: 814
• 26 Hindley RM, Baggaley KH. US4362892A, 1982
• 27 Kang X, Wu X, Han X, Yuan C, Liu Y, Cui Y. Chem. Sci. 2020; 11: 1494
• 28 Oishi S, Yoshimoto J, Saito S. J. Am. Chem. Soc. 2009; 131: 8748
• 29 Brzozowski M, Forni JA, Paul Savage G, Polyzos A. Chem. Commun. 2015; 51: 334
• 30 Dastbaravardeh N, Schnürch M, Mihovilovic MD. Eur. J. Org. Chem. 2013; 2878